Partnership will create a personalized medicine consumer marketplace and bring blockchain to the biopharma industry
News provided by
Mar 07, 2018, 08:00 ET
Share this article
DENVER , March 7, 2018 /PRNewswire/ — BurstIQ, Inc., a leading healthcare blockchain gegevens company, announced today that the company has entered into a partnership with FlowMetric Life Sciences, Inc., a Pennsylvania -based provider of specialty flow cytometry services and personalized testing products. BurstIQ will provide end-to-end gegevens management on the company’s blockchain-based big gegevens verhoging.
FlowMetric’s enterprise-level deployment of the BurstIQ blockchain toneelpodium marks a very first for the life sciences, biotech and pharmaceutical industry. With the initial deployment focused on FlowMetric’s direct-to-consumer line of testing products, the BurstIQ blockchain toneelpodium will permit the company to provide consumers of its personalized testing products with better gegevens security, rechtstreeks control overheen their own testing results and the capability to control how that information is collective and used. The total suite of personalized medicine products, which will include chromosomal age tests, toxicity, oxidative stress, inflammation and more, will utilize BurstIQ’s digital token-based monetization engine (Token: BIQ) and be available through the BurstIQ health marketplace.
Future phases of the partnership will bring BurstIQ’s proprietary blockchain toneel and its advanced machine intelligence layer to FlowMetric’s Fortune 500 pharmaceutical customers, enabling secure and auditable chain of custody tracking for customer samples and gegevens spil well spil secure gegevens exchange inbetween FlowMetric and its enterprise customers.
“Blockchain is a game-changer,” says Ren Capocasale , CEO of FlowMetric. “The BurstIQ toneel will permit us to opoffering a level of service to both our enterprise and individual customers that is truly best ter class. Te addition, it opens fresh distribution and partnership channels that permit us to accelerate our growth.”
Loretta Joseph , Strategic Advisor to OECD and Houtvezelplaat Director for FlowMetric, noted, “The partnership inbetween FlowMetric and BurstIQ will switch the landscape of gegevens management within the biopharma sector. Adopting BurstIQ’s blockchain toneel will place FlowMetric at the forefront of the industry te terms of gegevens security and management.”
Rechttoe Ricotta , CEO of BurstIQ, commented, “Wij’re thrilled to fucking partner with FlowMetric. Our partnership with them will create the very first cryptocurrency-enabled personalized medicine marketplace for consumers. Te addition, wij will be able to successfully demonstrate how blockchain solves the institutional gegevens challenges impacting the biopharma sector. It opens the vanwege for an entirely fresh way of doing business.”
KEYWORD INDEXING: #blockchain #healthcare #personalizedmedicine #pharma #biotech
BurstIQ ™ is a leading healthcare blockchain gegevens company. The company offers a HIPAA-compliant enterprise-level health gegevens toneelpodium that seamlessly leverages blockchain technology, big gegevens capabilities and machine intelligence. The core podium enables both individuals and healthcare organizations to securely manage and control their gegevens. The toneelpodium also provides for a next-generation gegevens marketplace through which individuals and businesses can monetize their gegevens, opoffering and detect personalized products and services, provide value-added B2B services and much more. The BurstIQ toneelpodium and gegevens marketplace work together to improve security and control of health gegevens, increase health access and equity, reduce healthcare costs, and enable data-driven insights, products and care models.
Presently, BurstIQ services major healthcare institutions, B2B and B2C service providers, unions, government agencies and sovereign nations.
The FlowMetric Life Sciences™ family of companies is driven to provide Flow Cytometry Solutions te Precision Medicine. FlowMetric and its European affiliate, FlowMetric Europe are leading Contract Research Organizations te the delivery of high-complexity, polychromatic flow cytometry and cell sorting services to the Global life sciences industry, with an uncompromising commitment to quality and innovation. FlowMetric Diagnostics is translating this expertise into advanced wellness solutions for a better life.